{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:18:05Z","timestamp":1784243885427,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jceh.2021.11.011","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T02:19:21Z","timestamp":1637806761000},"page":"808-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-8875","authenticated-orcid":false,"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia D.","family":"Rempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-940X","authenticated-orcid":false,"given":"Gerald Y.","family":"Minuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.11.011_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.11.011_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.011_bib3","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.dld.2014.02.010","article-title":"Intestinal permeability is\u00a0increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity","volume":"46","author":"Giorgio","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2021.11.011_bib5","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2021.11.011_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children","volume":"50","author":"Alisi","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2021.11.011_bib7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fimmu.2019.01192","article-title":"Natural killer cells and type 1 innate lymphoid cells are new actors in non-alcoholic fatty liver disease","volume":"10","author":"Luci","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2021.11.011_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/he.2000.5634","article-title":"Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4","volume":"31","author":"Su","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/j.gastro.2016.09.048","article-title":"Innate immune cell trafficking and function during sterile inflammation of the liver","volume":"151","author":"McDonald","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.011_bib10","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1182\/blood-2006-10-049817","article-title":"Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease","volume":"110","author":"Luft","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2021.11.011_bib11","doi-asserted-by":"crossref","first-page":"9729107","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic value of CK-18, FGF-21, and related biomarker panel in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"2017","author":"He","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2021.11.011_bib12","doi-asserted-by":"crossref","first-page":"8341030","DOI":"10.1155\/2016\/8341030","article-title":"Systemic and splanchnic lipopolysaccharide and endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt","volume":"2016","author":"Meng","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jceh.2021.11.011_bib13","doi-asserted-by":"crossref","first-page":"E1140","DOI":"10.1152\/ajpendo.00268.2002","article-title":"Splanchnic free fatty acid kinetics","volume":"284","author":"Jensen","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.11.011_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/hep.21511","article-title":"Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms","volume":"45","author":"Aborsangaya","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00125-010-1747-3","article-title":"Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet","volume":"53","author":"Ehses","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2021.11.011_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to\u00a0the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.011_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-9255-9-48","article-title":"Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation","volume":"9","author":"Ahmad","year":"2012","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.jceh.2021.11.011_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.223.227","article-title":"Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease","volume":"223","author":"Kim","year":"2011","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jceh.2021.11.011_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","article-title":"Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients","volume":"16","author":"Paredes-Turrubiarte","year":"2016","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jceh.2021.11.011_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1203\/01.pdr.0000195101.74184.e3","article-title":"Lipopolysaccharide-induced human enterocyte tolerance to cytokine-mediated interleukin-8 production may occur independently of TLR-4\/MD-2 signaling","volume":"59","author":"Savidge","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jceh.2021.11.011_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm1196-1174","article-title":"Chemokine receptors: gateways to inflammation and infection","volume":"2","author":"Premack","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2021.11.011_bib24","first-page":"1858","article-title":"CCR1 and CCR5 promote\u00a0hepatic\u00a0fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2021.11.011_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.ASN.0000111246.87175.32","article-title":"Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction","volume":"15","author":"Eis","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2021.11.011_bib26","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.011_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehp308","article-title":"Monocyte heterogeneity in obesity and subclinical atherosclerosis","volume":"31","author":"Rogacev","year":"2010","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jceh.2021.11.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168610","article-title":"Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets","volume":"11","author":"Mattos","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2021.11.011_bib29","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1038\/s41598-018-29735-6","article-title":"Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin","volume":"8","author":"Ogawa","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2021.11.011_bib30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:40Z","timestamp":1760854060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321005752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0973688321005752"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.011","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}